Steward Partners Investment Advisory LLC Grows Stake in HCA Healthcare, Inc. (NYSE:HCA)

Steward Partners Investment Advisory LLC increased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 49.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,993 shares of the company’s stock after purchasing an additional 655 shares during the quarter. Steward Partners Investment Advisory LLC’s holdings in HCA Healthcare were worth $539,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the business. Norges Bank purchased a new position in HCA Healthcare during the 4th quarter valued at approximately $694,985,000. Northern Trust Corp grew its holdings in HCA Healthcare by 3.2% during the 3rd quarter. Northern Trust Corp now owns 2,152,419 shares of the company’s stock valued at $529,452,000 after buying an additional 67,332 shares in the last quarter. Morgan Stanley lifted its stake in shares of HCA Healthcare by 1.4% in the 3rd quarter. Morgan Stanley now owns 2,150,009 shares of the company’s stock valued at $528,860,000 after purchasing an additional 30,072 shares during the last quarter. Invesco Ltd. lifted its stake in shares of HCA Healthcare by 5.0% in the 3rd quarter. Invesco Ltd. now owns 2,146,844 shares of the company’s stock valued at $528,081,000 after purchasing an additional 102,025 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its stake in shares of HCA Healthcare by 0.6% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,126,550 shares of the company’s stock valued at $304,935,000 after purchasing an additional 6,407 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 6,311 shares of the firm’s stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $316.88, for a total value of $1,999,829.68. Following the completion of the transaction, the executive vice president now owns 29,624 shares in the company, valued at approximately $9,387,253.12. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, SVP Chad J. Wasserman sold 344 shares of the firm’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $321.97, for a total transaction of $110,757.68. Following the completion of the sale, the senior vice president now directly owns 2,452 shares in the company, valued at $789,470.44. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Michael S. Cuffe sold 6,311 shares of the firm’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $316.88, for a total transaction of $1,999,829.68. Following the sale, the executive vice president now owns 29,624 shares of the company’s stock, valued at $9,387,253.12. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 13,617 shares of company stock worth $4,321,986. Company insiders own 1.60% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the company. Oppenheimer raised their price objective on HCA Healthcare from $330.00 to $345.00 and gave the company an “outperform” rating in a research note on Monday, April 29th. Royal Bank of Canada raised their price target on HCA Healthcare from $322.00 to $329.00 and gave the stock an “outperform” rating in a research note on Monday, April 29th. StockNews.com lowered HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Friday, May 31st. Baird R W upgraded shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, May 30th. Finally, Wells Fargo & Company boosted their price objective on shares of HCA Healthcare from $303.00 to $315.00 and gave the company an “equal weight” rating in a research report on Thursday, March 28th. Four equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $325.59.

View Our Latest Stock Analysis on HCA

HCA Healthcare Price Performance

Shares of HCA opened at $336.67 on Friday. HCA Healthcare, Inc. has a fifty-two week low of $215.96 and a fifty-two week high of $340.00. The company has a 50 day moving average price of $319.23 and a 200-day moving average price of $309.99. The company has a debt-to-equity ratio of 29.26, a quick ratio of 1.02 and a current ratio of 1.16. The stock has a market capitalization of $88.18 billion, a PE ratio of 16.78, a PEG ratio of 1.54 and a beta of 1.69.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its quarterly earnings data on Friday, April 26th. The company reported $5.36 EPS for the quarter, beating the consensus estimate of $5.01 by $0.35. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The firm had revenue of $17.34 billion during the quarter, compared to analyst estimates of $16.81 billion. During the same quarter in the prior year, the business posted $4.93 EPS. The business’s revenue for the quarter was up 11.2% compared to the same quarter last year. Equities analysts predict that HCA Healthcare, Inc. will post 20.86 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Shareholders of record on Friday, June 14th will be given a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 0.78%. The ex-dividend date is Friday, June 14th. HCA Healthcare’s dividend payout ratio is presently 13.16%.

About HCA Healthcare

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Recommended Stories

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.